Current Portion Of Long Term Debt - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Current Portion of Long-Term Debt
$1.4B
CAGR 3-Years
-19%
CAGR 5-Years
2%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Current Portion of Long-Term Debt
$3.1B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
24%
Pfizer Inc
NYSE:PFE
Current Portion of Long-Term Debt
$3.7B
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
-4%
Merck & Co Inc
NYSE:MRK
Current Portion of Long-Term Debt
$3.1B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Current Portion of Long-Term Debt
$5.2B
CAGR 3-Years
43%
CAGR 5-Years
20%
CAGR 10-Years
87%

See Also

Back to Top